KLOW is a next-generation research-only peptide formulation combining GHK-Cu, BPC-157, TB-500, and KPV. This advanced blend is developed to support laboratory research focused on cellular balance, tissue signaling, and inflammatory pathway modulation in controlled experimental settings.

KLOW is designed for researchers investigating peptide synergy related to tissue integrity, cellular communication, and protective signaling mechanisms.

Key Research Components

GHK-Cu (Copper Peptide) – Studied for its role in cellular signaling, extracellular matrix communication, and gene expression related to tissue structure.

BPC-157 – A synthetic peptide fragment researched for cellular protection, angiogenic signaling, and tissue resilience.

TB-500 – A thymosin beta fragment investigated for its involvement in actin regulation, cell migration, and tissue repair signaling.

KPV – A tripeptide fragment studied for its interaction with inflammatory response pathways and cellular homeostasis.

Research Focus Areas

• Cellular regeneration and signaling pathways

• Tissue integrity and structural balance

• Inflammatory pathway modulation

• Advanced peptide synergy research

Quality & Specifications

• High-purity peptide blend (≥99%)

• Lyophilized for enhanced laboratory stability

• Independently tested for identity and purity

• Manufactured in controlled research-grade facilities

Important Notice

For Research Use Only.

This product is not intended for human or animal consumption, clinical use, or diagnostic purposes. Intended exclusively for qualified researchers conducting laboratory and in-vitro research.